A Multidisciplinary Approach: Management and Rehabilitation of Children With Pediatric Post-COVID-19 Condition
Lieke Noij,Suzanne Terheggen-Lagro,Eefje Muselaers,Elizabeth Whittaker,Justine Gosling,Caroline Brackel,Kim Oostrom,Mattijs Alsem
DOI: https://doi.org/10.1097/inf.0000000000004408
2024-08-23
The Pediatric Infectious Disease Journal
Abstract:Infections with SARS-CoV-2, also known as coronavirus disease 2019 (COVID-19), are relatively mild in children, with only a small percentage leading to hospital admissions. 1 , 2 There is however, a subgroup of children who suffer from long-term symptoms and impairments in neurocognitive, psychosocial and physical functioning with decreased societal participation after infection with SARS-CoV-2. 3–5 This condition, known as Long COVID or postacute sequelae of SARS-CoV-2 infection in adults, is in children commonly referred to as pediatric post-COVID-19 condition (PPCC), and was defined by the World Health Organization as "symptoms lasting at least 2 months, which initially occurred within 3 months of acute COVID-19, which cannot be explained by an alternative diagnosis." 6 The pathophysiology of PPCC is poorly characterized and not yet fully understood, 1 , 7 however, the following possible underlying mechanisms for post-COVID-19 syndrome in adults have been described: immune dysregulation (eg, due to viral persistence), microbiota dysbiosis, autoimmunity and immune priming, clotting and endothelial abnormalities, and/or dysfunctional neurological signaling. 8–11 The reported prevalence of PPCC has a wide range of 1.6% to 67%, 12 , 13 which could be due to differences in study populations (hospitalized vs. nonhospitalized), different follow-up approaches, or lack of consensus on PPCC definitions. The most common PPCC symptoms include fatigue, mood symptoms, headache, cognitive difficulties, respiratory symptoms and loss of smell. 14 , 15
pediatrics,immunology,infectious diseases